Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Cash from Investing Activities: 2012-2024

Historic Cash from Investing Activities for Neurogene (NGNE) over the last 13 years, with Dec 2024 value amounting to -$125.3 million.

  • Neurogene's Cash from Investing Activities rose 175.92% to $22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$118.2 million, marking a year-over-year decrease of 3811.81%. This contributed to the annual value of -$125.3 million for FY2024, which is 588.59% down from last year.
  • As of FY2024, Neurogene's Cash from Investing Activities stood at -$125.3 million, which was down 588.59% from $25.6 million recorded in FY2023.
  • In the past 5 years, Neurogene's Cash from Investing Activities ranged from a high of $25.6 million in FY2023 and a low of -$125.3 million during FY2024.
  • Over the past 3 years, Neurogene's median Cash from Investing Activities value was -$2.2 million (recorded in 2022), while the average stood at -$34.0 million.
  • Per our database at Business Quant, Neurogene's Cash from Investing Activities spiked by 1,249.64% in 2023 and then crashed by 588.59% in 2024.
  • Over the past 5 years, Neurogene's Cash from Investing Activities (Yearly) stood at -$2.2 million in 2020, then tumbled by 47.05% to -$3.3 million in 2021, then spiked by 31.66% to -$2.2 million in 2022, then skyrocketed by 1,249.64% to $25.6 million in 2023, then crashed by 588.59% to -$125.3 million in 2024.